Monthly Pulse Methylprednisolone Therapy is Effective in Preventing Permanent Disease Progression in Secondary Progressive Multiple Sclerosis


Creative Commons License

ÖZAKBAŞ S., Cinar B. P., Oz D., Kosehasanogullari G., Kursun B. B., Kahraman T.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, vol.56, no.2, pp.115-118, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 56 Issue: 2
  • Publication Date: 2019
  • Doi Number: 10.5152/npa.2017.19339
  • Journal Name: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.115-118
  • Keywords: Secondary progressive multiple sclerosis, monthly methylprednisolone treatment, disease progression, IV METHYLPREDNISOLONE, TRIAL
  • Dokuz Eylül University Affiliated: Yes

Abstract

Introduction: Secondary progressive multiple sclerosis (SPMS) is the phase in which disability continues to worsen with or without accompanying attacks. Monthly methylprednisolone pulse therapy can be used in the secondary progressive phase. The purpose of the present study was to evaluate the effects of methylprednisolone pulse therapy on the basis of clinical and MRI parameters in patients with SPMS.